Wei Cao

Dr. Wei Cao


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2022 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
XZXieyu Zhang
Xieyu Zhang
XZXinwen Zhang
Xinwen Zhang
YYYue Yang
Yue Yang
KZKai Zhi
Kai Zhi
YCYili Chen
Yili Chen
WCWei Cao
Wei Cao

1 December 2024 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
YYYue Yang
Yue Yang
JSJinjie Shi
Jinjie Shi
JYJiming Yu
Jiming Yu
XZXin Zhao
Xin Zhao
KZKe Zhu
Ke Zhu
WCWei Cao
Wei Cao
Lactic acid (LA) is an essential glycolytic metabolite and energy source in the body, which is present in high levels in the synovial fluid of patients with rheumatoid arthritis (RA) and is a reliable indicator for identifying inflammatory arthritis. LA not only acts as an inflammatory amplifier in RA, recent studies have found that novel posttranslational modification (PTM) lactylation mediated by LA may also play a key role in RA. Single-cell sequencing showed that the RA lactylation score of patients with RA was significantly increased, and core lactylation-promoting genes, including NDUFB3, NGLY1, and other genes, were found to be potential biomarkers of RA. More studies have shown that lactylation can regulate genes in various cells, such as fibroblast-like synoviocytes (FLSs) and macrophages, thus playing a special role in the development and occurrence of autoimmune diseases, neurological diseases, and cancer diseases. In this paper, we review the research on lactylation in RA-related cells and mechanisms and bring new insights into the pathogenesis, diagnosis, and treatment of RA.

12 July 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
XZXieyu Zhang
Xieyu Zhang
XZXinwen Zhang
Xinwen Zhang
XLXiaoxu Li
Xiaoxu Li
XZXin Zhao
Xin Zhao
GWGuangcheng Wei
Guangcheng Wei
WCWei Cao
Wei Cao
Background: The evidence supporting a connection between elevated serum uric acid (SUA) levels and diabetic peripheral neuropathy (DPN) is controversial. The present study performed a comprehensive evaluation of this correlation by conducting a systematic review and meta-analysis of relevant research.Method: PubMed, Web of Science (WOS), Embase, and the Cochrane Library were searched for published literature from the establishment of each database to January 8, 2024. In total, 5 cohort studies and 15 cross-sectional studies were included, and 2 researchers independently screened and extracted relevant data. R 4.3.0 was used to evaluate the included literature. The present meta-analysis evaluated the relationship between SUA levels and the risk of DPN in type 2 diabetes (T2DM) by calculating the ratio of means (RoM) and 95% confidence intervals (CIs) using the method reported by JO Friedrich, and it also analyzed continuous outcome measures using standardized mean differences (SMDs) and 95% CIs to compare SUA levels between DPN and non-DPN groups. Funnel plot and Egger’s test were used to assess publication bias. Sensitivity analysis was conducted by sequentially removing each study one-by-one.Results: The meta-analysis included 20 studies, with 12,952 T2DM patients with DPN and 16,246 T2DM patients without DPN. There was a significant correlation between SUA levels and the risk of developing DPN [odds ratio (OR) = 1.23; 95% CI: 1.07-1.41; p = 0.001]. Additionally, individuals with DPN had higher levels of SUA compared to those without DPN (SMD = 0.4; 95% CI: -0.11-0.91; p < 0.01).Conclusion: T2DM patients with DPN have significantly elevated SUA levels, which correlate with a heightened risk of peripheral neuropathy. Hyperuricemia (HUA) may be a risk indicator for assessing the risk of developing DPN in T2DM patients.Systematic review registration: https://www.crd.york.ac.uk/PROSPERO, identifier CRD42024500373.

14 February 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
YTYujun Tang
Yujun Tang
HLHaichang Li
Haichang Li
LHLin Huang
Lin Huang
QWQiao Wang
Qiao Wang
YHYongmei Han
Yongmei Han
CWChengping Wen
Chengping Wen
Introduction: Rheumatoid arthritis (RA) is an autoimmune disease characterized by progressive bone erosion on diarthrodial joints. RA patients usually experienced three stages before final diagnosis: the health period, the pre-clinical period (immune response exists without clinical symptoms), and the pre-RA period (immune response exists with mild inflammatory manifestation). Presently, there is seldom guidance referring to early intervention which is a benefit for stable disease conditions and low morbidity. Prophylactic treatment is a major feature of traditional Chinese medicine (TCM). In this present study, a multi-center, double-blind, placebo-controlled clinical trial is carried out to evaluate both efficacy and safety in preventing RA progression on Yunpi Qufeng Chushi formula (YQCF).Method: The multi-center, double-blind, placebo-controlled clinical trial is conducted in 13 hospitals nationwide. A total of 390 patients ages between 18 and 70 will be recruited in the trial. They will be randomly assigned to the intervention group (YQCF) and placebo group. The follow-up visit will be taken every 3 months from baseline to 1 year. Diagnosis, disease activity scores, clinical disease activity index (CDAI), simplified disease activity index (SDAI), TCM syndrome scores, and safety assessments will be recorded at every visit. Joint color doppler ultrasound, health assessment questionnaire-disability index (HAQ-DI), and functional assessment of chronic illness therapy-fatigue (FACIT-F) will be recorded at baseline and the last visit.Discussion: This work will provide evidence of YQCF in preventing RA progression. However, whether early intervention would benefit the controlling RA disease still needs a long-term follow-up.Ethics and dissemination: Protocol version 2 (201910-1). This research was approved by the medical ethics committee of Zhejiang Chinese Medical University (2019-045). Results will be published in a peer-reviewed academic journal.Trial registration numbers:http://www.chictr.org.cn/index.aspx, ChiCTR1900024166.

22 January 2025 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
XZXinwen Zhang
Xinwen Zhang
GWGuangcheng Wei
Guangcheng Wei
XZXieyu Zhang
Xieyu Zhang
JGJunyi Guo
Junyi Guo
JZJiahe Zhao
Jiahe Zhao
WCWei Cao
Wei Cao

2 March 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
RMRui Ma
Rui Ma
YMYujia Ma
Yujia Ma
XLXiaoyi Li
Xiaoyi Li
KDKeXin Ding
KeXin Ding
HXHan Xiao
Han Xiao
WCWei Cao
Wei Cao
Background: Handgrip strength (HGS) is a robust indicator of muscle strength and overall health, yet its relationship with serum uric acid (SUA) remains unclear due to limitations in linear modeling. This study investigated the nonlinear relationship between SUA and HGS using repeated-measures cohort data. Methods: The cohort consisted of 3016 community-dwelling Chinese adults contributing 4439 repeated measurements (2021–2024). SUA was measured via the uricase–peroxidase method, and HGS was measured via digital dynamometry. Nonlinear associations were evaluated using restricted cubic spline (RCS) linear mixed-effects models and subgroup and sensitivity analyses. Results: No significant linear association was found (p = 0.170). However, RCS analysis revealed an inverted U-shaped curve of the peak HGS at approximately 404 μmol/L SUA (p for nonlinearity < 0.05). When SUA ≤ 404 μmol/L, each standard deviation increase in SUA was associated with a 1.74 kg increase in HGS (p = 0.003), and when SUA > 404 μmol/L, each standard deviation elevation in SUA corresponded to a 0.57 kg decrease in HGS (p = 0.049). This inverted U-shaped relationship was significant in men and participants without type 2 diabetes mellitus (T2DM) but was not observed in women (p for interaction < 0.05) or T2DM patients. Sensitivity analyses confirmed the validity of these results. Conclusions: An inverted U-shaped relationship between SUA and HGS was observed in Chinese adults with an inflection point at approximately 404 μmol/L, modified by sex and notably observed in non-T2DM participants. The results suggest that both low and high SUA levels may impair muscle function, highlighting SUA’s potential as a biomarker for muscle decline and the importance of population-specific management strategies.